Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy.
- Resource Type
- Article
- Source
- Biomacromolecules; 12/11/2023, Vol. 24 Issue 12, p5780-5796, 17p
- Subject
- Language
- ISSN
- 15257797